Industrial Psychiatry Journal

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 28  |  Issue : 2  |  Page : 286--293

Therapeutic and prophylactic role of cognitive enhancers in electroconvulsive therapy-induced cognitive deficits


Jyoti Prakash1, Suprakash Chaudhury2, Kaushik Chatterjee1, A Kotwal3, Kalpana Srivastava1, Amitav Saha4 
1 Department of Psychiatry, Armed Forces Medical College, Hospital and Research Centre, Dr. DY Patil Vidyapeeth, Pune, Maharashtra, India
2 Department of Psychiatry, Dr. DY Patil Medical College, Hospital and Research Centre, Dr. DY Patil Vidyapeeth, Pune, Maharashtra, India
3 Department of Community Medicine, Army College of Medical Science, Delhi, India
4 Department of Psychiatry, Base Hospital, Barrackpore, West Bengal, India

Correspondence Address:
Dr. Suprakash Chaudhury
Department of Psychiatry, Dr. DY Patil Medical College, Hospital and Research Centre, Dr. DY Patil Vidyapeeth, Pimpri, Pune, Maharashtra
India

Objectives: The objective is to evaluate the pattern of cognitive deficits after electroconvulsive therapy (ECT); to ascertain the role of various psychosocial, illness and treatment-related parameters on cognitive functions after ECT; and to evaluate the effect of donepezil on various cognitive deficits. Materials and Methods: A triple-blind randomized controlled trial was undertaken. Ninety patients undergoing ECT were included into study after due consent and institutional ethical approval. They were randomized into two groups: one using donepezil with ECT and the other using placebo with ECT. Various cognitive parameters were studied before ECT, after a course of ECT and after 4 weeks of last ECT. Findings were assessed in the light of available socialdemographic and clinical parameters and existing literature. Results: ECT was found to be an effective therapeutic modality. Immediate memory worsened over the course of ECT till after 4 weeks of ECT. Augmentation of donepezil was found useful. It sped up the improvement of general memory and working memory during ECT. Conclusion: Donepezil has therapeutic and prophylactic benefit on cognition of patients undergoing ECT over the course of treatment till 4 weeks after the ECT.


How to cite this article:
Prakash J, Chaudhury S, Chatterjee K, Kotwal A, Srivastava K, Saha A. Therapeutic and prophylactic role of cognitive enhancers in electroconvulsive therapy-induced cognitive deficits.Ind Psychiatry J 2019;28:286-293


How to cite this URL:
Prakash J, Chaudhury S, Chatterjee K, Kotwal A, Srivastava K, Saha A. Therapeutic and prophylactic role of cognitive enhancers in electroconvulsive therapy-induced cognitive deficits. Ind Psychiatry J [serial online] 2019 [cited 2020 Dec 3 ];28:286-293
Available from: https://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2019;volume=28;issue=2;spage=286;epage=293;aulast=Prakash;type=0